WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007001086) ORALLY DISINTEGRATING POWDER COMPRISING CILOSTAZOL AND MANNITOL
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/001086    International Application No.:    PCT/JP2006/313345
Publication Date: 04.01.2007 International Filing Date: 28.06.2006
IPC:
A61K 9/16 (2006.01), A61K 31/4709 (2006.01)
Applicants: OTSUKA PHARMACEUTICAL CO., LTD. [JP/JP]; 9, Kandatsukasa-cho 2-chome, Chiyoda-ku, Tokyo, 1018535 (JP) (For All Designated States Except US).
TODA, Masafumi [JP/JP]; (JP) (For US Only).
MUKAI, Tadashi [JP/JP]; (JP) (For US Only)
Inventors: TODA, Masafumi; (JP).
MUKAI, Tadashi; (JP)
Agent: KAWAMIYA, Osamu; AOYAMA & PARTNERS, IMP Building, 3-7, Shiromi 1-chome, Chuo-ku, Osaka-shi, Osaka 5400001 (JP)
Priority Data:
2005-190156 29.06.2005 JP
Title (EN) ORALLY DISINTEGRATING POWDER COMPRISING CILOSTAZOL AND MANNITOL
(FR) POUDRE A DESINTEGRATION PAR VOIE ORALE, COMPRENANT DU CILOSTAZOL ET DU MANNITOL
Abstract: front page image
(EN)The present invention provides an orally disintegrating powder comprising cilostazol as an active ingredient and mannitol in an amount of 70% by weight or more, which can be taken without water and can be disintegrated in oral cavity. Said powder is suitable for patients to whom cilostazol is applied, especially for aged patients and patients suffering from dysphagia.
(FR)L'invention concerne une poudre à désintégration par voie orale, comprenant du cilostazol comme ingrédient actif, et du mannitol, à raison de 70 % en poids, ou plus, pouvant être prise sans eau et pouvant se désintégrer dans la cavité buccale. Ladite poudre est appropriée pour des patients auxquels on doit administrer du cilostazol, en particulier, pour des patients agés et pour des patients souffrant de dysphagie.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)